93 related articles for article (PubMed ID: 18046889)
1. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review.
Poole PJ; Black PN
BMJ; 2001 May; 322(7297):1271-4. PubMed ID: 11375228
[TBL] [Abstract][Full Text] [Related]
2. Role of N-acetylcysteine in the management of COPD.
Sadowska AM; Verbraecken J; Darquennes K; De Backer WA
Int J Chron Obstruct Pulmon Dis; 2006; 1(4):425-34. PubMed ID: 18044098
[TBL] [Abstract][Full Text] [Related]
3. Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies.
Schiffers C; Reynaert NL; Wouters EFM; van der Vliet A
Antioxidants (Basel); 2021 Nov; 10(11):. PubMed ID: 34829671
[TBL] [Abstract][Full Text] [Related]
4. Anaesthesia for patient with chronic obstructive pulmonary disease.
Duggappa DR; Rao GV; Kannan S
Indian J Anaesth; 2015 Sep; 59(9):574-83. PubMed ID: 26556916
[TBL] [Abstract][Full Text] [Related]
5. Role of mucolytics in the management of COPD.
Poole PJ
Int J Chron Obstruct Pulmon Dis; 2006; 1(2):123-8. PubMed ID: 18046889
[TBL] [Abstract][Full Text] [Related]
6. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Black PN
Cochrane Database Syst Rev; 2010 Feb; (2):CD001287. PubMed ID: 20166060
[TBL] [Abstract][Full Text] [Related]
7. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole PJ; Black PN
Cochrane Database Syst Rev; 2006 Jul; (3):CD001287. PubMed ID: 16855965
[TBL] [Abstract][Full Text] [Related]
8. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Chong J; Cates CJ
Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
[TBL] [Abstract][Full Text] [Related]
9. The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).
Davies L; Calverley PM
Br Med Bull; 2010; 93():217-27. PubMed ID: 20031934
[TBL] [Abstract][Full Text] [Related]
10. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
11. High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Demedts M; Behr J; Buhl R; Costabel U; Dekhuijzen R; Jansen HM; MacNee W; Thomeer M; Wallaert B; Laurent F; Nicholson AG; Verbeken EK; Verschakelen J; Flower CD; Capron F; Petruzzelli S; De Vuyst P; van den Bosch JM; Rodriguez-Becerra E; Corvasce G; Lankhorst I; Sardina M; Montanari M;
N Engl J Med; 2005 Nov; 353(21):2229-42. PubMed ID: 16306520
[TBL] [Abstract][Full Text] [Related]
12. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial.
Decramer M; Rutten-van Mölken M; Dekhuijzen PN; Troosters T; van Herwaarden C; Pellegrino R; van Schayck CP; Olivieri D; Del Donno M; De Backer W; Lankhorst I; Ardia A
Lancet; 2005 Apr 30-May 6; 365(9470):1552-60. PubMed ID: 15866309
[TBL] [Abstract][Full Text] [Related]
13. Inhaled tiotropium for stable chronic obstructive pulmonary disease.
Barr RG; Bourbeau J; Camargo CA; Ram FS
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002876. PubMed ID: 15846642
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]